Indivior Pharmaceuticals, Inc.
INDV
$34.44
-$0.33-0.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 222.00M | 175.00M | 195.00M | 445.00M | 510.00M |
| Total Receivables | 287.00M | 285.00M | 255.00M | 272.00M | 243.00M |
| Inventory | 150.00M | 152.00M | 153.00M | 155.00M | 149.00M |
| Prepaid Expenses | 14.00M | 15.00M | 34.00M | 30.00M | 28.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 52.00M | 40.00M | 15.00M | 20.00M | 21.00M |
| Total Current Assets | 725.00M | 667.00M | 652.00M | 922.00M | 951.00M |
|
|
|||||
| Total Current Assets | 725.00M | 667.00M | 652.00M | 922.00M | 951.00M |
| Net Property, Plant & Equipment | 183.00M | 179.00M | 170.00M | 154.00M | 152.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.00M | 2.00M | 2.00M | 2.00M | 7.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 296.00M | 322.00M | 349.00M | 310.00M | 315.00M |
| Total Assets | 1.23B | 1.20B | 1.20B | 1.42B | 1.45B |
|
|
|||||
| Total Accounts Payable | 30.00M | 35.00M | 48.00M | 41.00M | 50.00M |
| Total Accrued Expenses | 786.00M | 694.00M | 784.00M | 787.00M | 855.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.00M | 9.00M | 39.00M | 28.00M | 29.00M |
| Total Finance Division Other Current Liabilities | 43.00M | 41.00M | 43.00M | 109.00M | 122.00M |
| Total Other Current Liabilities | 43.00M | 41.00M | 43.00M | 109.00M | 122.00M |
| Total Current Liabilities | 868.00M | 779.00M | 914.00M | 965.00M | 1.06B |
|
|
|||||
| Total Current Liabilities | 868.00M | 779.00M | 914.00M | 965.00M | 1.06B |
| Long-Term Debt | 487.00M | 486.00M | 290.00M | 304.00M | 308.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.00M | 14.00M | 22.00M | 24.00M | 29.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 73.00M | 62.00M | 73.00M | 330.00M | 316.00M |
| Total Liabilities | 1.44B | 1.34B | 1.30B | 1.62B | 1.71B |
|
|
|||||
| Common Stock & APIC | 155.00M | 165.00M | 174.00M | 171.00M | 163.00M |
| Retained Earnings | -334.00M | -280.00M | -243.00M | -346.00M | -388.00M |
| Treasury Stock & Other | -29.00M | -29.00M | -29.00M | -32.00M | -32.00M |
| Total Common Equity | -208.00M | -144.00M | -98.00M | -207.00M | -257.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -208.00M | -144.00M | -98.00M | -207.00M | -257.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -208.00M | -144.00M | -98.00M | -207.00M | -257.00M |
|
|
|||||